{"filings":[{"id":861756,"accession_number":"0001628280-26-040823","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2026-06-04T20:27:28+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"CooperCompanies Q2 revenue $1.082B (+8% YoY); non-GAAP EPS $1.21 (+26%); records $271.6M litigation charge","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Revenue $1.082B (+8% reported, +5% organic); CooperVision $723.5M (+8%), CooperSurgical $358.0M (+8%).","GAAP diluted EPS of $(0.40) due to $271.6M net litigation charge; non-GAAP diluted EPS $1.21, up 26% YoY.","Recorded $271.6M net charge ($324.1M liabilities less $52.5M insurance) for CooperSurgical fertility media recall; settled >95% of over 1,500 claimants.","Fiscal 2026 guidance: revenue $4.285-$4.321B; non-GAAP diluted EPS $4.58-$4.66; reaffirms long-term free cash flow target >$2.2B for FY26-28.","Repurchased $13.1M in common stock (174k shares) at avg $75.84; $860.8M remaining under buyback authorization."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":98416,"accession_number":"0001628280-26-029853","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2026-05-04T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"CooperCompanies appoints Paul Keel to Board of Directors effective July 1, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board size increased from 9 to 10 directors; Keel fills new director seat.","Keel is President and CEO of Envista Holdings (NYSE: NVST) since 2024.","Previously CEO of Smiths Group plc and 16-year 3M veteran including Group President of Consumer Business.","Keel appointed to Audit Committee effective July 1, 2026.","Compensation consistent with other non-employee directors as disclosed in February 2026 proxy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":98415,"accession_number":"0001628280-26-024273","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2026-04-08T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Cooper Companies announces results of 2026 annual meeting; all proposals pass","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All nine director nominees elected with >92% of votes cast (excluding broker non-votes).","Ratification of KPMG as FY2026 auditor passed with 177.5M for, 8.7M against.","Advisory say-on-pay approved with 162.9M votes for (89.1% of votes cast)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113866,"accession_number":"0001628280-26-015231","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2026-03-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CooperCompanies Q1 revenue $1.024B, non-GAAP EPS $1.10; raises FY2026 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 revenue $1.024B (+6% reported, +3% organic); GAAP EPS $0.66 (+27%), non-GAAP EPS $1.10 (+20%).","CVI revenue $695.1M (+8% reported, +3% organic); Toric/multifocal +10% reported, sphere +5%.","CSI revenue $329.0M (+3% reported, +2% organic); Fertility +6% reported, Office/surgical +2%.","FY2026 guidance raised: revenue $4.306-$4.346B, non-GAAP EPS $4.58-$4.66, free cash flow $600-$625M.","Repurchased $92.5M in stock (~1.1M shares at avg $82.04); $873.9M remaining authorization."],"consensus_eps_estimate":null,"consensus_eps_actual":0.66,"consensus_revenue_estimate":null,"consensus_revenue_actual":1024100000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113865,"accession_number":"0001193125-26-036476","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2026-02-04T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Cooper Companies extends $950M term loan maturity to 2031, removes credit spread adjustment","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Extended $950M of term loans to maturity date February 3, 2031; $550M remain at original maturity.","Removed credit spread adjustment and increased incremental term loan cap to greater of $1.365B or 100% EBITDA.","Also amended revolving credit facility to conform provisions, including removal of credit spread adjustments.","Both amendments executed on February 3, 2026 with lenders including PNC, Bank of America, Citibank, and others."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130273,"accession_number":"0001193125-25-331117","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2025-12-23T23:59:59+00:00","items":["1.01","5.02","7.01","9.01"],"status":"ready","headline":"CooperCompanies appoints former STERIS CEO Rosebrough to board; agrees with Browning West","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Walter M. Rosebrough Jr., former STERIS CEO, appointed as independent director effective Jan 3, 2026; joins Governance & Nominating Committee.","Board will consider appointing Rosebrough as Chair by end of 2026 and add another independent director with medtech experience by June 30, 2026, subject to Browning West approval.","Cooperation agreement with Browning West includes customary standstill and voting commitments through 30 days before 2027 annual meeting deadline.","Rosebrough led STERIS from 2007-2021, delivering 18% annualized total return and growing market cap by over $20B.","Incoming Board Chair Colleen Jay welcomes the appointment; Browning West's CIO Usman Nabi calls it a constructive path forward."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130272,"accession_number":"0001628280-25-056796","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2025-12-12T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cooper Companies CFO Andrews adds principal accounting officer role","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Brian G. Andrews, EVP/CFO/Treasurer, assumed principal accounting officer duties on Dec 9, 2025.","Agostino Ricupati relinquished the role but remains SVP Tax; no compensation change for Andrews.","Andrews has been CFO since 2018 and EVP since 2020; no arrangements or family relationships noted."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130271,"accession_number":"0001628280-25-055405","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2025-12-04T23:59:59+00:00","items":["2.02","5.02","7.01","9.01"],"status":"ready","headline":"CooperCompanies reports Q4 FY2025 revenue up 5%, appoints new Chairman, launches strategic review","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 FY2025 revenue $1,065.2M (+5% reported, +3% organic); GAAP EPS $0.43 (-27%), non-GAAP EPS $1.15 (+11%)","FY2025 revenue $4.1B (+5% reported, +4% organic); non-GAAP EPS $4.13 (+12%)","Chairman Robert Weiss resigns effective Jan 2, 2026; Colleen Jay appointed as new Chairman","Board initiates formal strategic review to explore partnerships, divestitures, or other transactions to unlock value","FY2026 guidance: revenue $4.299-$4.338B, non-GAAP EPS $4.45-$4.60, free cash flow $575-$625M; long-term FCF target $2.2B+"],"consensus_eps_estimate":null,"consensus_eps_actual":1.87,"consensus_revenue_estimate":null,"consensus_revenue_actual":4092400000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146845,"accession_number":"0000711404-25-000046","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2025-08-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CooperCompanies Reports Q3 2025 Revenue of $1.0603B, Up 6%; Non-GAAP EPS $1.10, Up 15%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue grew 6% to $1,060.3 million; CooperVision up 6% to $718.4M, CooperSurgical up 4% to $341.9M.","GAAP diluted EPS fell 6% to $0.49; non-GAAP diluted EPS rose 15% to $1.10, driven by margin improvement.","Free cash flow was $164.6 million, with operating cash flow of $261.5M and capex of $96.9M.","Company repurchased $52.1M of stock (~724,300 shares) at average price of $71.97; $163.6M remaining.","Raised FY2025 non-GAAP EPS guidance to $4.08-$4.12; Q4 revenue expected $1.049B-$1.069B."],"consensus_eps_estimate":null,"consensus_eps_actual":1.45,"consensus_revenue_estimate":null,"consensus_revenue_actual":3027300000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165280,"accession_number":"0000711404-25-000036","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2025-05-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CooperCompanies Q2 revenue $1.00B, up 6% YoY; non-GAAP EPS $0.96 (+14%)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $1,002.3M (+6% YoY); GAAP EPS $0.44 flat; non-GAAP EPS $0.96 (+14%).","CooperVision revenue $669.6M (+5% reported, +7% organic); CooperSurgical $332.7M (+8% reported, +7% organic).","FY2025 guidance: total revenue $4,107-4,146M (organic +5-6%), non-GAAP EPS $4.05-4.11.","Q2 share repurchases $40.6M (~537k shares at avg $75.60); $215.8M remaining in program.","Gross margin improved to 68% (GAAP/non-GAAP) from 67% YoY; operating margin 18% GAAP, 25% non-GAAP."],"consensus_eps_estimate":0.9369,"consensus_eps_actual":0.96,"consensus_revenue_estimate":null,"consensus_revenue_actual":1967000000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165279,"accession_number":"0000711404-25-000027","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2025-04-30T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"CooperCompanies appoints Barbara Carbone to Board of Directors, effective May 1, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board expanded from 7 to 8 directors; Carbone appointed as independent director.","Carbone also appointed to Audit Committee; former KPMG audit partner with 38 years experience.","Currently serves on boards of TrueCar, Limoneira, and Bob's Discount Furniture.","Compensation consistent with standard non-employee director package as described in proxy.","Appointment effective May 1, 2025; fills newly created board seat."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165278,"accession_number":"0000711404-25-000022","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2025-04-02T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Cooper Companies annual meeting elects directors, passes officer exculpation amendment","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All seven director nominees elected including Colleen Jay, Lawrence Kurzius, Cynthia Lucchese, Teresa Madden, Maria Rivas, Robert Weiss, Albert White.","Amendment to certificate of incorporation to exculpate officers approved with 88.2% of votes cast.","KPMG LLP ratified as independent auditor for fiscal 2025 with 92.5% of votes cast.","Advisory vote on executive compensation passed with 90.1% of votes cast."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":182945,"accession_number":"0000711404-25-000010","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2025-03-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CooperCompanies Q1 revenue $964.7M (+4% YoY); non-GAAP EPS $0.92; raises FY EPS outlook to $3.94-$4.02","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $964.7M (+4% reported, +5% constant currency, +5% organic); GAAP diluted EPS $0.52 (vs $0.41), non-GAAP diluted EPS $0.92 (vs $0.85).","CooperVision revenue $646.1M (+4% reported, +6% constant currency); toric/multifocal up 10% organic. CooperSurgical $318.6M (+3% reported, +4% constant currency).","Free cash flow $101.2M; gross margin 68% GAAP (69% non-GAAP), operating margin 19% GAAP (25% non-GAAP).","FY2025 revenue guidance $4,080-$4,158M (organic growth 6-8%); non-GAAP EPS raised to $3.94-$4.02 from $3.92-$4.02."],"consensus_eps_estimate":null,"consensus_eps_actual":0.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":964700000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":182944,"accession_number":"0000711404-25-000001","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2025-02-05T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cooper Companies director William A. Kozy to retire at April 2025 annual meeting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["William A. Kozy informed the Board he will retire as director effective at the 2025 Annual Meeting in April.","No disagreements exist between Mr. Kozy and the Company regarding operations, policies, or practices.","No replacement director has been announced as of the filing date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199533,"accession_number":"0000711404-24-000069","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2024-12-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CooperCompanies Q4 revenue $1.02B (+10% YoY), non-GAAP EPS $1.04, up 19%; FY25 guide $4.08-$4.16B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $1,018.4M (+10% YoY), GAAP EPS $0.58 (+38%), non-GAAP EPS $1.04 (+19%).","FY2024 revenue $3.9B (+8%), non-GAAP EPS $3.69 (+15%); record consolidated revenues.","CVI revenue $676.4M (+8% organic), CSI revenue $342.0M (+5% organic).","FY2025 guidance: revenue $4.08-$4.16B (6-8% organic), non-GAAP EPS $3.92-$4.02.","Free cash flow Q4 $128.2M, FY $288.1M; gross margin 67% non-GAAP."],"consensus_eps_estimate":null,"consensus_eps_actual":1.96,"consensus_revenue_estimate":null,"consensus_revenue_actual":3895400000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199532,"accession_number":"0000711404-24-000065","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2024-10-25T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Cooper Companies amends bylaws with universal proxy and exclusive forum provisions","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Bylaw amendments include universal proxy rule compliance and white proxy card reserved for Board.","Exclusive forum designated: Delaware Chancery Court for internal corporate claims; federal courts for Securities Act claims.","Enhanced advance notice requirements for stockholder proposals and director nominations, including background disclosures.","Company may enforce exclusive forum provisions against stockholders suing in other jurisdictions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":215572,"accession_number":"0000711404-24-000058","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2024-08-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CooperCompanies Q3 revenue up 8% to $1,002.8M; raises FY 2024 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $1,002.8M (+8% YoY); GAAP diluted EPS $0.52 (+22%), non-GAAP diluted EPS $0.96 (+14%).","CooperVision revenue $675.6M (+7% YoY); CooperSurgical $327.2M (+9%).","FY2024 guidance raised: revenue $3,892-$3,913M, non-GAAP EPS $3.64-$3.67.","Q4 FY2024 guidance: revenue $1,015-$1,036M, non-GAAP EPS $0.98-$1.01.","Operating cash flow $207.5M; free cash flow $118.5M; GAAP gross margin 66%, non-GAAP 67%."],"consensus_eps_estimate":null,"consensus_eps_actual":1.37,"consensus_revenue_estimate":null,"consensus_revenue_actual":2877000000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":234914,"accession_number":"0000711404-24-000038","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2024-05-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CooperCompanies Q2 revenue $942.6M (+7% YoY), raises FY2024 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP diluted EPS $0.44 (up 122% YoY); non-GAAP diluted EPS $0.85 (up 10% YoY).","CVI revenue $635.9M (+8% reported, +11% organic); CSI revenue $306.7M (+6% reported, +4% organic).","Free cash flow $36.9M; total debt $2.7B, cash $112.4M; interest expense $28.9M.","FY2024 guidance raised: revenue $3.863-$3.905B, non-GAAP EPS $3.54-$3.60."],"consensus_eps_estimate":null,"consensus_eps_actual":0.85,"consensus_revenue_estimate":null,"consensus_revenue_actual":1874200000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":234913,"accession_number":"0000711404-24-000024","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2024-05-01T23:59:59+00:00","items":["1.01","1.02","2.03","9.01"],"status":"ready","headline":"Cooper Companies enters $2.3B revolving credit facility, terminates prior facility","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $2.3B multicurrency revolver with $1B sublimit for non-USD borrowings, maturing May 1, 2029.","Initial pricing: ABR loans +12.5bps; SOFR loans +112.5bps; grid adjusts based on leverage or debt rating.","Commitment fee ranges from 0.10% to 0.20% of unused portion; facility is unsecured and guaranteed by domestic subs.","Entered Amendment No. 2 to 2021 Term Loan Agreement conforming certain provisions; terminated 2020 Credit Agreement on May 1, 2024.","Company may increase facility or add term loans up to greater of $1.15B or 100% consolidated EBITDA."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":252758,"accession_number":"0000711404-24-000021","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2024-03-22T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Cooper Companies stockholders elect 8 directors at 2024 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All eight director nominees elected; highest votes for Albert G. White III (44,225,910 for) and Cynthia L. Lucchese (43,915,382 for).","KPMG LLP ratified as independent auditor for FY ending Oct 31, 2024: 41,225,096 for, 3,660,265 against, 816,216 abstain.","Advisory vote on executive compensation approved: 40,001,914 for, 4,406,987 against, 16,807 abstain, with 1,275,869 broker non-votes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":252757,"accession_number":"0000711404-24-000016","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2024-02-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cooper Q1 revenue record $931.6M (+9% YoY); non-GAAP EPS $0.85 (+18%); FY24 guidance raised","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $931.6M, up 9% YoY; CooperVision $621.5M (+7%), CooperSurgical $310.1M (+12%).","GAAP EPS $0.41 (down 5% YoY); non-GAAP EPS $0.85 (up 18% YoY).","Gross margin improved to 67% (GAAP and non-GAAP) from 65%/66% last year.","FY2024 guidance raised: revenue $3,847-$3,897M, non-GAAP EPS $3.50-$3.58.","4-for-1 stock split effective Feb 20, 2024; free cash flow $4.6M; net debt $2.6B."],"consensus_eps_estimate":null,"consensus_eps_actual":0.41,"consensus_revenue_estimate":null,"consensus_revenue_actual":931600000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":252756,"accession_number":"0000711404-24-000010","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2024-02-16T23:59:59+00:00","items":["3.03","5.03","8.01","9.01"],"status":"ready","headline":"CooperCompanies announces 4-for-1 stock split effective Feb. 16, 2024","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Stock split ratio 4:1; effective 5:00 PM ET on Feb 16; trading starts split-adjusted Feb 20.","Authorized shares increased from 120M to 480M; par value unchanged at $0.10 per share.","New CUSIP number for post-split common stock is 216648501; symbol COO unchanged.","Split aims to make stock ownership more accessible to employees and investors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":270237,"accession_number":"0000711404-23-000073","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2023-12-14T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cooper Companies director Gary Petersmeyer to retire at March 2024 annual meeting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Gary S. Petersmeyer notified the Board of his retirement effective at the 2024 Annual Meeting in March 2024.","No disagreements between Mr. Petersmeyer and the Company regarding operations, policies, or practices.","No replacement has been announced as of the filing date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":270236,"accession_number":"0000711404-23-000068","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2023-12-07T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Cooper Q4 revenue $927M (+9%); FY2024 guidance $3.81-3.88B; 4-for-1 stock split","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP diluted EPS $1.70 (+29%); non-GAAP diluted EPS $3.47 (+26%). FY GAAP EPS $5.91 (-24%), non-GAAP $12.81 (+3%).","CooperVision Q4 revenue $622.9M (+11% YoY) led by toric (+18%) and multifocal (+22%) lenses.","CooperSurgical Q4 revenue $304.2M (+6%), fertility up 12%.","FY2024 guidance: revenue $3.809-3.877B; non-GAAP EPS $13.60-14.00.","Board approved 4-for-1 stock split (effective Feb 16, 2024) and will end de minimis semi-annual dividend."],"consensus_eps_estimate":null,"consensus_eps_actual":5.91,"consensus_revenue_estimate":null,"consensus_revenue_actual":3593200000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":270235,"accession_number":"0000711404-23-000056","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2023-11-30T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"CooperCompanies appoints Lawrence E. Kurzius to board as independent director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board expanded from eight to nine directors; Kurzius effective Dec 1, 2023.","Kurzius appointed to Audit Committee and Organization & Compensation Committee.","Kurzius previously served as CEO of McCormick & Company (2016-2023).","Director compensation per proxy; no transactions requiring disclosure."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":287215,"accession_number":"0000711404-23-000047","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2023-09-12T23:59:59+00:00","items":["3.01","7.01","9.01"],"status":"ready","headline":"CooperCompanies to transfer stock listing from NYSE to Nasdaq, effective September 26, 2023","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board authorized voluntary delisting from NYSE; last trading on NYSE expected September 25, 2023.","Trading on Nasdaq to commence at market open on September 26, 2023 under same ticker 'COO'.","Nasdaq listing has been approved; company cites growth and innovation as rationale."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":287214,"accession_number":"0000711404-23-000040","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2023-08-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CooperCompanies Q3 revenue $930.2M (+10% YoY); non-GAAP EPS $3.35 (+5%); guides FY23 revenue $3.578-3.595B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $930.2M up 10% YoY; record quarterly revenue for both CooperVision and CooperSurgical.","GAAP diluted EPS $1.71 down 14% YoY; non-GAAP diluted EPS $3.35 up 5% YoY.","CooperVision revenue $630.2M (+11% YoY); CooperSurgical revenue $300.0M (+8% YoY).","FY2023 guidance: revenue $3.578-3.595B (organic growth 9-10%), non-GAAP EPS $12.72-12.90.","Free cash flow $51.6M; net debt $2.5B."],"consensus_eps_estimate":null,"consensus_eps_actual":4.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":2666100000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":307315,"accession_number":"0000711404-23-000029","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2023-06-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cooper Q2 revenue up 6% to $877M; GAAP EPS slumps 69% to $0.80; FY23 guidance updated","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $877.4M, up 6% YoY (9% constant currency, 8% organic); GAAP diluted EPS $0.80 vs $2.55 last year.","Non-GAAP diluted EPS $3.08, down $0.16 or 5% YoY; gross margin 66% on GAAP, 67% non-GAAP.","CooperVision organic growth 10% (9th consecutive double-digit quarter); CooperSurgical fertility up 11% organic.","FY23 guidance: revenue $3,512-$3,569M (organic 7-9%), non-GAAP EPS $12.66-$12.96.","Free cash flow $50.6M; net debt $2.5B down $48.5M from prior quarter; interest expense $26.1M."],"consensus_eps_estimate":null,"consensus_eps_actual":2.5,"consensus_revenue_estimate":null,"consensus_revenue_actual":1735900000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":326347,"accession_number":"0000711404-23-000016","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2023-03-16T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Cooper Companies annual meeting approves all proposals including LTIP and auditor ratification","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 8 director nominees elected; votes for ranged from 39.8M to 44.5M; broker non-votes 1.6M.","KPMG ratified as independent auditor for FY2023 with 41.4M for, 4.7M against.","2023 Long-Term Incentive Plan approved with 40.9M for, 3.7M against.","Advisory vote on executive compensation approved with 38.4M for; annual frequency of vote also approved."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":326346,"accession_number":"0000711404-23-000008","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2023-03-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CooperCompanies Q1 revenue up 9% to $858.5M; guides FY23 non-GAAP EPS $12.60-$12.90","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $858.5M, up 9% YoY (16% constant currency, 10% organic).","GAAP EPS $1.70, down 11% YoY; non-GAAP EPS $2.90, down 10% YoY.","CooperVision revenue $581.3M (+4% YoY); CooperSurgical $277.2M (+23% YoY).","Fiscal 2023 guidance: revenue $3,496-$3,553M, non-GAAP EPS $12.60-$12.90.","Net debt $2.6B, down $47.7M from prior quarter; free cash flow $83.6M."],"consensus_eps_estimate":null,"consensus_eps_actual":1.7,"consensus_revenue_estimate":null,"consensus_revenue_actual":858500000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":344058,"accession_number":"0000711404-22-000058","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2022-12-19T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Director Jody S. Lindell to retire at March 2023 annual meeting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Director Jody S. Lindell will retire from the Board effective at the company's March 2023 Annual Meeting.","Ms. Lindell's retirement is not due to any disagreement with the company over operations, policies, or practices.","The Committee approved the 2023 Incentive Payment Plan with cash targets for executives (CEO 125%, COO 80%, CFO 75%)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":344057,"accession_number":"0000711404-22-000046","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2022-12-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CooperCompanies Q4 revenue up 12% to $848M, but GAAP EPS falls 40%; FY2023 guidance issued","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP diluted EPS of $1.32 (down 40% YoY); non-GAAP diluted EPS of $2.75 (down 16%).","Full-year FY2022 revenue $3,308.4M (+13% YoY); GAAP EPS $7.76 (down 87%), non-GAAP EPS $12.42 (down 6%).","Q4 CooperVision revenue $561.8M (down 1% reported but +10% constant currency); CooperSurgical revenue $286.3M (+47% reported).","FY2023 guidance: revenue $3,455-$3,515M (6-8% organic growth); non-GAAP EPS $12.30-$12.60.","Pending Cook Medical Reproductive Health acquisition ($875M) not included in FY2023 guidance; awaits regulatory approval."],"consensus_eps_estimate":null,"consensus_eps_actual":7.76,"consensus_revenue_estimate":null,"consensus_revenue_actual":3308400000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":344056,"accession_number":"0001193125-22-257592","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2022-10-04T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"CooperCompanies appoints Cynthia Lucchese to Board of Directors, effective Oct 1, 2022","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Cynthia Lucchese appointed as independent director, expanding board from 8 to 9 members.","Lucchese will serve on the Audit Committee and Corporate Governance & Nominating Committee.","Lucchese is Chief Strategy Officer of Penske Entertainment; previously CFO of Hillenbrand.","No material arrangements or transactions with Lucchese; compensation consistent with other non-employee directors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":360563,"accession_number":"0000711404-22-000038","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2022-08-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cooper Q3 revenue $843.4M (+10% YoY); non-GAAP EPS $3.19 down 6%; FY22 guide $3.29-3.31B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $843.4M (+10% YoY); CooperVision +2% to $566.3M, CooperSurgical +35% to $277.1M.","GAAP diluted EPS $1.98 (down $10.39); non-GAAP diluted EPS $3.19 (down 6% vs $3.41).","Non-GAAP gross margin 66% (down 200bps); non-GAAP operating margin 23% (down 400bps).","Free cash flow $217.3M; net debt $2.6B (down $218M QoQ); adjusted leverage 2.44x.","FY2022 guidance: revenue $3.29-3.31B, non-GAAP EPS $12.72-$12.87; Q4 rev $830-850M."],"consensus_eps_estimate":null,"consensus_eps_actual":6.44,"consensus_revenue_estimate":null,"consensus_revenue_actual":2460300000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":379643,"accession_number":"0000711404-22-000023","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2022-06-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CooperCompanies Q2 rev up 15% to $829.8M; GAAP EPS $2.55, adj EPS $3.24","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["CooperVision revenue $553.8M (+6% reported, +12% organic); toric and multifocal sales strong.","CooperSurgical revenue $276.0M (+40% reported, +6% organic); fertility segment organic growth 15%.","FY2022 guidance: revenue $3.28-3.312B, non-GAAP diluted EPS $13.09-13.29, reflecting FX headwinds.","Exited contact lens solutions business in April; closed SightGlass JV with EssilorLuxottica in March."],"consensus_eps_estimate":null,"consensus_eps_actual":4.45,"consensus_revenue_estimate":null,"consensus_revenue_actual":1616900000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":397827,"accession_number":"0001193125-22-079445","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2022-03-18T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Cooper Companies annual meeting results: all directors elected, auditor ratified, say-on-pay passes","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All eight director nominees elected; highest vote count for Maria Rivas (43.7M for) and Albert White (43.5M for).","KPMG LLP ratified as independent auditor for FY ending Oct 31, 2022: 41.5M for, 3.9M against.","Advisory vote on executive compensation approved: 40.0M for, 4.1M against, 44K abstain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":397826,"accession_number":"0000711404-22-000010","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2022-03-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CooperCompanies Q1 revenue up 16% to $787M; non-GAAP EPS $3.24","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $787.2M (+16% YoY); CooperVision +11% to $561.5M, CooperSurgical +30% to $225.7M.","GAAP diluted EPS $1.91 (vs $42.31 prior year due to deferred tax benefit); non-GAAP diluted EPS $3.24 (+2%).","Net debt $2,981.5M after Generate Life Sciences acquisition; adjusted leverage 2.71x.","FY2022 guidance: revenue $3,261-$3,329M; non-GAAP EPS $13.70-$14.20."],"consensus_eps_estimate":null,"consensus_eps_actual":1.91,"consensus_revenue_estimate":null,"consensus_revenue_actual":787200000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":397825,"accession_number":"0001193125-22-029799","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2022-02-07T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"CooperCompanies to acquire Cook Medical's Reproductive Health business for $875M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Deal consideration: $675M at closing plus $200M in four $50M annual installments.","Cook's Reproductive Health had ~$158M revenue in 2021, up ~17% YoY in constant currency.","Expected to be accretive to non-GAAP EPS by ~$0.60 in the first year after closing.","Acquisition enhances CooperSurgical's international fertility footprint and ObGyn device portfolio.","Closing subject to regulatory approvals, definitive agreement, and local consultation requirements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":416818,"accession_number":"0001193125-21-361145","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2021-12-17T23:59:59+00:00","items":["1.01","2.01","2.03","7.01","9.01"],"status":"ready","headline":"CooperCompanies completes $1.6B acquisition of Generate Life Sciences, funded by $1.5B term loan","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Cooper completed acquisition of Generate Life Sciences for ~$1.605B in cash.","Generate provides donor egg/sperm, fertility cryopreservation, and newborn stem cell storage.","Acquisition funded by a $1.5B non-amortizing 5-year senior unsecured term loan.","Term loan matures Dec 17, 2026; bears interest at LIBOR + 75bps or base rate.","CooperSurgical adds Generate to strengthen fertility clinic and Ob/Gyn offerings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":416817,"accession_number":"0001193125-21-353917","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2021-12-10T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cooper Companies adopts 2022 Incentive Payment Plan; CEO target 125% of salary","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Albert White receives 125% target eligibility; Threshold Goal requires 50% achievement of Revenue, Income, or EPS.","COO McBride (80% target) and CFO Andrews (75% target) included; Corporate HQ weighting: Revenue 50%, Income 25%, EPS 25%.","Payment may be cash and up to 50% common stock; CEO above 75% may get restricted stock with 3-year cliff vesting.","Plan is part of 2017 Executive Incentive Program; Committee may reduce quantitative-based bonus by up to 25% for qualitative factors.","Participants forfeit awards if employment terminates before year-end unless due to death, retirement, or disability."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":416816,"accession_number":"0000711404-21-000030","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2021-12-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CooperCompanies reports record FY2021 revenue; Q4 revenue up 11% to $759.1M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $759.1M (+11% YoY); GAAP EPS $2.21 (+35%); Non-GAAP EPS $3.28 (+4%)","FY2021 revenue $2,922.5M (+20%); Non-GAAP EPS $13.24 (+37%)","CooperVision rev $564.8M (+12%); CooperSurgical rev $194.3M (+11%)","FY2022 guidance: rev $3,032-3,090M (+6-8% cc); Non-GAAP EPS $13.60-14.00","Generate Life Sciences acquisition (announced Nov 10) not included in guidance"],"consensus_eps_estimate":null,"consensus_eps_actual":59.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":2922500000.0,"consensus_period":"2021-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":416815,"accession_number":"0001193125-21-326207","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2021-11-10T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"CooperCompanies to acquire Generate Life Sciences for $1.6B cash, expected to close Q1 2022","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["CooperSurgical unit will acquire Generate, a provider of donor egg/sperm, fertility cryopreservation, and newborn stem cell storage.","Aggregate cash consideration of $1.605 billion; transaction not subject to financing condition.","Generate reported trailing twelve-month revenue of ~$250M as of Sep 30, 2021.","Deal expected to be accretive to non-GAAP EPS by ~$0.30 in first year after closing, excluding one-time and amortization charges.","Closing anticipated in Cooper's first fiscal quarter of 2022 (starting Nov 1), subject to HSR and customary conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":416814,"accession_number":"0001193125-21-321676","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2021-11-05T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Cooper enters $840M 364-day unsecured term loan to replace maturing facility","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Term loan of $840M matures Nov 1, 2022; replaces prior 364-day facility that matured Oct 15, 2021.","Interest at LIBOR plus 60 bps (or alternate base rate); no amortization or mandatory prepayments.","Proceeds used to repay revolving borrowings and for general corporate purposes.","Loan unsecured; guaranteed by existing and future domestic material subsidiaries.","Covenants include total leverage and interest coverage ratios; customary events of default."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":434384,"accession_number":"0000711404-21-000021","cik":711404,"company_name":"COOPER COMPANIES, INC.","ticker":"COO","form_type":"8-K","filed_at":"2021-09-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cooper Q3 revenue up 32% to $763.4M; non-GAAP EPS $3.41, up 50%; raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $763.4M (+32% YoY); CooperVision $557.5M (+24%), CooperSurgical $205.9M (+60%).","Non-GAAP diluted EPS $3.41, up 50% YoY; GAAP EPS $12.37 (prior Q3: $1.12).","Free cash flow $180.2M; net debt $1,507.8M, adjusted leverage 1.52x.","FY2021 guidance: revenue $2,893-2,923M, non-GAAP EPS $13.20-13.40; Q4 revenue $730-760M.","Gross margin 68% (non-GAAP), up from 66%; operating margin 27% non-GAAP vs 23% last year."],"consensus_eps_estimate":null,"consensus_eps_actual":57.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":2163400000.0,"consensus_period":"2021-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":11862954990.707722,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}